Inflammation amplification by versican: The first mediator

International Journal of Molecular Sciences

Volumn 13, Issue 6, 2012, Pages 6873-6882

  Zhang, Zhenwei ^a   Miao, Lei ^b   Wang, Lianghua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Extracellular matrix homeostasis; Inflammation amplification; Versican

Indexed keywords

CD14 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; INTERLEUKIN 11; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR BB; TOLL LIKE RECEPTOR 6; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA; VERSICAN; CYTOKINE; LIGAND;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; INFLAMMATION AMPLIFICATION; MACROPHAGE; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; ANIMAL; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMANS; INFLAMMATION; LIGANDS; MICE; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; VERSICANS;

EID: 84862489198     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13066873     Document Type: Article

References (51)

1. Couzin-Frankel, J. Inflammation bares a dark side. Science 2010, 330, doi:10.1126/science. 330.6011.1621.
2. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
3. Mantovani, A. Inflaming metastasis. Nature 2009, 457, 36-37.
4. Grivennikov, S.I.; Greten, F.R.; Karin, M. Immunity, inflammation, and cancer. Cell 2010, 140, 883-899.
5. Gao, H.M.; Hong, J.S. Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends. Immunol. 2008, 29, 357-365.
6. Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140, 918-934.
7. Sorokin, L. The impact of the extracellular matrix on inflammation. Nature 2010, 10, 712-723.
8. Tímár, J.; Lapis, K.; Dudás, J.; Sebestyén, A.; Kopper, L.; Kovalszky, I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin. Cancer Biol. 2002, 12, 173-186.
9. Kinsella, M.G.; Bressler, S.L.; Wight, T.N. The regulated synthesis of versican, decorin and biglycan: Extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 2004, 14, 203-234.
10. Choocheep, K.; Hatano, S.; Takagi, H.; Watanabe, H.; Kimata, K.; Kongtawelert, P.; Watanabe, H. Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J. Biol. Chem. 2010, 285, 21114-21125.
11. McCulloch, D.R.; Nelson, C.M.; Dixon, L.J.; Silver, D.L.; Wylie, J.D.; Lindner, V.; Sasaki, T.; Cooley, M.A.; Argraves, W.S.; Apte, S.S. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev. Cell. 2009, 17, 687-698.
12. Wu, Y.J.; La Pierre, D.P.; Wu, J.; Yee, A.J.; Yang, B.B. The interaction of versican with its binding partners. Cell Res. 2005, 15, 483-494.
13. Zako, M.; Shinomura, T.; Ujita, M.; Ito, K.; Kimata, K. Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J. Biol. Chem. 1995, 270, 3914-3918.
14. Landolt, R.M.; Vaughan, L.; Winterhalter, K.H.; Zimmermann, D.R. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995, 121, 2303-2312.
15. Schmalfeldt, M.; Dours-Zimmermann, M.T.; Winterhalter, K.H.; Zimmermann, D.R. Versican V2 is a major extracellular matrix component of the mature bovine brain. J. Biol. Chem. 1998, 273, 15758-15764.
16. Ricciardelli, C.; Sakko, A.J.; Ween, M.P.; Russell, D.L.; Horsfall, D.J. The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 2009, 28, 233-245.
17. Zheng, P.S.; Vais, D.; Lapierre, D.; Liang, Y.Y.; Lee, V.; Yang, B.L.; Yang, B.B. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J. Cell Sci. 2004, 117, 5887-5895.
18. Dinarello, C.A. Anti-inflammatory agents: Present and future. Cell 2010, 140, 935-950.
19. Lin, W.W.; Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117, 1175-1183.
20. Hirsch, E.C.; Hunot, S. Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurol. 2009, 8, 382-397.
21. Sakko, A.J.; Ricciardelli, C.; Mayne, K.; Suwiwat, S.; LeBaron, R.G.; Marshall, V.R.; Tilley, W.D.; Horsfall, D.J. Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res. 2003, 63, 4786-4791.
22. Berdiaki, A.; Zafiropoulos, A.; Fthenou, E.; Katonis, P.; Tsatsakis, A.; Karamanos, N.K.; Tzanakakis, G.N. Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines. Biochim. Biophys. Acta 2008, 1780, 194-202.
23. Norian, J.M.; Malik, M.; Parker, C.Y.; Joseph, D.; Leppert, P.C.; Segars, J.H.; Catherino, W.H. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod. Sci. 2009, 16, 1153-1164.
24. Lemire, J.M.; Chan, C.K.; Bressler, S.; Miller, J.; LeBaron, R.G.; Wight, T.N. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J. Cell Biochem. 2007, 101, 753-766.
25. Schönherr, E.; Kinsella, M.G.; Wight, T.N. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch. Biochem. Biophys. 1997, 339, 353-361.
26. Gu, W.L.; Fu, S.L.; Wang, Y.X.; Li, Y.; Wang, X.F.; Xu, X.M.; Lu, P.H. Expression and regulation of versican in neural precursor cells and their lineages. Acta. Pharmacol. Sin. 2007, 28, 1519-1530.
27. Venkatesan, N.; Roughley, P.J.; Ludwig, M.S. Proteoglycan expression in bleomycin lung fibroblasts: Role of transforming growth factor-beta (1) and interferon-gamma. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283, L806-L814.
28. Zhang, Z.W.; Zhang, J.P.; Miao, L.; Liu, K.; Yang, S.S.; Pan, C.Y.; Jiao, B.H. Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican. Int. J. Biol. Sci. 2012, 8, 383-393.
29. Voutilainen, K.; Anttila, M.; Sillanpää, S.; Tammi, R.; Tammi, M.; Saarikoski, S.; Kosma, V.M. Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis. Int. J. Cancer 2003, 107, 359-364.
30. Takahashi, Y.; Kuwabara, H.; Yoneda, M.; Isogai, Z.; Tanigawa, N.; Shibayama, Y. Versican G1 and G3 domains are upregulated and latent transforming growth factor-β binding protein-4 is downregulated in breast cancer stroma. Breast Cancer 2012, 19, 46-53.
31. Pirinen, R.; Leinonen, T.; Böhm, J.; Johansson, R.; Ropponen, K.; Kumpulainen, E.; Kosma, V.M. Versican in nonsmall cell lung cancer: Relation to hyaluronan, clinicopathologic factors, and prognosis. Hum. Pathol. 2005, 36, 44-50.
32. Kodama, J.; Hasengaowa; Kusumoto, T. Seki, N. Matsuo, T.; Ojima, Y.; Nakamura, K.; Hongo, A.; Hiramatsu, Y. Prognostic significance of stromal versican expression in human endometrial cancer. Ann. Oncol. 2007, 18, 269-274.
33. Wu, Y.; Sheng, W.; Chen, L.; Chen, L.; Dong, H.; Lee, V.; Lu, F.; Wong, C.S.; Lu, W.Y.; Yang, B.B. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol. Biol. Cell 2004, 15, 2093-2104.
34. Sheng, W.; Wang, G.; Wang, Y.; Liang, J.; Wen, J.; Zheng, P.S.; Wu, Y.; Lee, V.; Slingerland, J.; Dumont, D.; Yang, B.B. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol. Biol. Cell 2005, 16, 1330-1340.
35. Zhang, Z.W.; Zhang, J.P.; Zhou, T.T.; Feng, W.H.; Jiao, B.H. Does the expression of versican isoforms contribute to the pathogenesis of neurodegenerative diseases? Arch. Med. Res. 2011, 42, 258-260.
36. Wight, T.N. Versican: A versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 2002, 14, 617-623.
37. Wu, Y.J.; Wu, J.; Lee, D.Y.; Yee, A.; Cao, L.; Zhang, Y.; Kiani, C.; Yang, B.B. Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol. 2005, 24, 3-13.
38. Gao, D.; Joshi, N.; Choi, H.; Ryu, S.; Hahn, M.; Catena, R.; Sadik, H.; Argani, P.; Wagner, P.L.; Vahdat, L.T. et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 2012, 72, 1384-1394.
39. De la Motte, C.A.; Hascall, V.C.; Drazba, J.; Bandyopadhyay, S.K.; Strong, S.A. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: Inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 2003, 163, 121-133.
40. Toeda, K.; Nakamura, K.; Hirohata, S.; Hatipoglu, O.F.; Demircan, K.; Yamawaki, H.; Ogawa, H.; Kusachi, S.; Shiratori, Y.; Ninomiya, Y. Versican is induced in infiltrating monocytes in myocardial infarction. Mol. Cell Biochem. 2005, 280, 47-56.
41. Kunisada, M.; Yogianti, F.; Sakumi, K.; Ono, R.; Nakabeppu, Y.; Nishigori, C. Increased expression of versican in the inflammatory response to UVB- and reactive oxygen species-induced skin tumorigenesis. Am. J. Pathol. 2011, 179, 3056-3065.
42. Potter-Perigo, S.; Johnson, P.Y.; Evanko, S.P.; Chan, C.K.; Braun, K.R.; Wilkinson, T.S.; Altman, L.C.; Wight, T.N. Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am. J. Respir. Cell Mol. Biol. 2010, 43, 109-120.
43. Brézin, A.P.; Nedelec, B.; Barjol, A.; Rothschild, P.R.; Delpech, M.; Valleix, S. A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features. Mol. Vis. 2011, 17, 1669-1678.
44. Kim, S.; Takahashi, H.; Lin, W.W.; Descargues, P.; Grivennikov, S.; Kim, Y.; Luo, J.L.; Karin, M. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457, 102-106.
45. Wang, W.; Xu, G.L.; Jia, W.D.; Ma, J.L.; Li, J.S.; Ge, Y.S.; Ren, W.H.; Yu, J.H.; Liu, W.B. Ligation of TLR2 by versican: A link between inflammation and metastasis. Arch. Med. Res. 2009, 40, 321-323.
46. Sozen, I.; Arici, A. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil. Steril. 2002, 78, 1-12.
47. Nikitovic, D.; Zafiropoulos, A.; Katonis, P.; Tsatsakis, A.; Theocharis, A.D.; Karamanos, N.K.; Tzanakakis, G.N. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells. IUBMB Life 2006, 58, 47-53.
48. Evanko, S.P.; Johnson, P.Y.; Braun, K.R.; Underhill, C.B.; Dudhia, J.; Wight, T.N. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch. Biochem. Biophys. 2001, 394, 29-38.
49. Wight, T.N.; Merrilees, M.J. Proteoglycans in atherosclerosis and restenosis: Key roles for versican. Circ. Res. 2004, 94, 1158-1167.
50. Kawashima, H.; Atarashi, K.; Hirose, M.; Hirose, J.; Yamada, S.; Sugahara, K.; Miyasaka, M. Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-Odisulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 2002, 277, 12921-12930.
51. Hirose, J.; Kawashima, H.; Yoshie, O.; Tashiro, K.; Miyasaka, M. Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 2001, 276, 5228-5234.